Clinical trial
Large-Scale Randomized Clinical Trial Assessing Intensive Blood Pressure Control for Reduction of Major Cardiovascular Events in Patients With Diabetes Mellitus (OPTIMAL-DIABETES)
NCT04040634 is registered in ClinicalTrials.gov with Hospital Israelita Albert Einstein as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Large-Scale Randomized Clinical Trial Assessing Intensive Blood Pressure Control for Reduction of Major Cardiovascular Events in Patients With Diabetes Mellitus (OPTIMAL-DIABETES)
- Lead sponsor
- Hospital Israelita Albert Einstein
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 8, 2019
- Completion date
- July 8, 2026
- Enrollment
- 9,476 (actual)
- Sites
- 32
Conditions
As the registry lists them; a condition with its own page is linked.
cardiovascular diseases, cognitive impairment, diabetes mellitus, high blood pressure